Genae is a Medical Device Contract Research Organization (CRO) and service provider for the medical industries. The offering to its customers consists of services in clinical research (project management, site management, site selection, auditing, monitoring), regulatory & safety (submissions, AE reporting, DSMB/CEC, reimbursement, legal representation, trial design) and e-solutions (data management, statistics, electronic data tools). The company has been involved in more than 225 clinical trials involving 600 sites in 40 countries. The types of studies include both pre-market, post market and IDE studies. Their expertise includes cardiology, urology, and many other fields.
Korys invested a first time in genae in 2016, becoming its sole equity partner and had since then been supporting the company along its impressive growth trajectory, boosted by a number of strategic acquisitions.
In 2019, genae announced the sale to a leading global CRO.